CODIAK BIOSCIENCES INC
CODIAK BIOSCIENCES INC logo
CDAK

CODIAK BIOSCIENCES INC (CDAK)

$0.80647.52%

Market is closed
– opens on 8 PM, 06 Feb 2023
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$0.75
Day's Range
$0.936
$0.3
52-Week Range
$7.15
1 month return49.33%
3 month return1.01%
1 year return83.9%
5 year return93.35%

Analyst Recommendation

based on 10 analysts ratings

Buy
80%
Buy
20%
Hold
0%
Sell

Based on 10 Wall street analysts offering stock ratings for CODIAK BIOSCIENCES INC(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 619.25%

Current

$0.81

Target

$5.8

Recommendation Trend

Based on 10 analyst

Current1M Ago3M Ago
Buy
8
3
8
Hold
2
0
2
Sell
0
0
0
Consensus
BUY
BUY
BUY

Highlights

Market Capitalization29.3M
Book Value$1.06
Dividend Share0.0
Dividend Yield0.0%
Earnings Per Share (EPS)-1.56
Wall Street Target Price5.8

Valuation

Trailing PE0.0
Forward PE0.0
Price/Book (mrq)0.55
Enterprise Value30.9M
Enterprise Value/Revenue0.92
Enterprise Value/Ebitda-3.28

Technicals

Beta3.46
50 Day MA0.58
200 Day MA1.73

Institutional Holdings

FMR Inc

12.17%

Flagship Ventures Management, Inc.

9.61%

LAURION CAPITAL MANAGEMENT LP

5.47%

Armistice Capital, LLC

2.72%

Alaska Permanent Fund Corp

2.66%

University Of Texas Investment Mgmt Co

2.3%

Company Information

Codiak is a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics, a new class of medicines with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need. By leveraging the biology of exosomes as natural intercellular transfer mechanisms, Codiak has developed its proprietary engEx Platform to expand upon the innate properties of exosomes to design, engineer and manufacture novel exosome therapeutic candidates. Codiak has utilized its engEx Platform to generate a deep pipeline of engineered exosomes aimed at treating a broad range of diseases, spanning oncology, neuro-oncology, neurology, neuromuscular disease and infectious disease.
OrganizationCODIAK BIOSCIENCES INC
Employees102
CEODr. Douglas Edward Williams Ph.D.
IndustryCommercial Services

Discover more

Frequently Asked Questions

What is CODIAK BIOSCIENCES INC share price today?

Can Indians buy CODIAK BIOSCIENCES INC shares?

How can I buy CODIAK BIOSCIENCES INC shares from India?

Can Fractional shares of CODIAK BIOSCIENCES INC be purchased?

What are the documents required to start investing in CODIAK BIOSCIENCES INC stocks?

What are today’s High and Low prices of CODIAK BIOSCIENCES INC?

What are today’s traded volumes of CODIAK BIOSCIENCES INC?

What is today’s market capitalisation of CODIAK BIOSCIENCES INC?

What is the 52 Week High and Low Range of CODIAK BIOSCIENCES INC?

How much percentage CODIAK BIOSCIENCES INC is down from its 52 Week High?

How much percentage CODIAK BIOSCIENCES INC is up from its 52 Week low?

What are the historical returns of CODIAK BIOSCIENCES INC?

Who is the Chief Executive Officer (CEO) of CODIAK BIOSCIENCES INC?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*